KKR Genetic Disorder L.P.

Insider Reports History

Location
New York, NY
Signature
See Exhibit 99.1
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KKR Genetic Disorder L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. 10%+ Owner Common Stock 13,260,971 $453,525,208 $34.20 12 May 2025 Indirect

Insider Reports Filed by KKR Genetic Disorder L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BBIO BridgeBio Pharma, Inc. 12 May 2025 1 -$205,200,000 4 10%+ Owner 14 May 2025, 17:24
BBIO BridgeBio Pharma, Inc. 05 Mar 2025 1 -$197,760,000 4 10%+ Owner 07 Mar 2025, 18:09
BBIO BridgeBio Pharma, Inc. 13 Sep 2024 1 -$149,350,000 4 10%+ Owner 17 Sep 2024, 18:44